A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis. (Q48352331)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 May 2017

Language	Label	Description	Also known as
English	A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis.	scientific article published on 31 May 2017

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

polycythemia vera

1 reference

based on heuristic

inferred from title

Paola Guglielmelli

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Francesco Albano

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Alessandro Rambaldi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Jean-Jacques Kiladjian

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Francesca Palandri

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

F Passamonti

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

B Mora

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

E Rumi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

M Maffioli

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

M Caramella

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

R Komrokji

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

J Gotlib

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

F Cervantes

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

T Devos

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

V De Stefano

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

M Ruggeri

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

R T Silver

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

G Benevolo

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

D Caramazza

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

R Casalone

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

G Rotunno

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

T Barbui

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

M Cazzola

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

A M Vannucchi

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

publication date

31 May 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

2726-2731

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

https://scigraph.springernature.com/pub.10.1038/leu.2017.169

0 references

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Update from the latest WHO classification of MPNs: a user's manual.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukemic transformation of polycythemia vera: a single center study of 23 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations and prognosis in primary myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

An accurate, simple prognostic model consisting of age, JAK2, CALR, and MPL mutation status for patients with primary myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Driver mutations' effect in secondary myelofibrosis: an international multicenter study based on 781 patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

How to develop a more accurate risk prediction model when there are few events.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Regularization Paths for Generalized Linear Models via Coordinate Descent

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Does ruxolitinib improve survival of persons with MPN-associated myelofibrosis? Should it?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Ruxolitinib and survival improvement in patients with myelofibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Does ruxolitinib prolong the survival of patients with myelofibrosis?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk models predicting survival after reduced-intensity transplantation for myelofibrosis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-related clonal hematopoiesis associated with adverse outcomes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent advances in understanding myelofibrosis and essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2017.169

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2017.169

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28561069%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48352331&oldid=1531434477"